Sun.May 20, 2018

article thumbnail

Why Hearing “No” in a Fund-Raising Process is Actually Healthy

Both Sides of the Table

Every entrepreneur wants to hear “yes” during the fund-raising process but I would argue that being too risk averse and not pushing hard enough and be willing to hear a “no” is what holds back many people from “yes.” I believe people generally hate making decisions and especially so when they involve commitments and risks. This is true of any buying process where a customer has to make a large investment decision on your software or when an investor must decide whether to give you $5 million.

Funding 189
article thumbnail

Fixing the Clinical Trial Bottleneck by Making Patients a Priority

Xconomy

The world of medicine and drug development has transformed dramatically over the past 50 years. Today, we have biologic medicines, genomic sequencing technologies, and digital health tools that help patients become more engaged in their care. But one part of the equation hasn’t seen very much change at all: clinical trials. Clinical trials are a necessary component of bringing any drug to market.